Is MetLife (MET) Stock Outpacing Its Finance Peers This Year?

MET

The Finance group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has MetLife (MET - Free Report) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.

MetLife is a member of the Finance sector. This group includes 854 individual stocks and currently holds a Zacks Sector Rank of #10. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. MET is currently sporting a Zacks Rank of #2 (Buy).

Over the past 90 days, the Zacks Consensus Estimate for MET's full-year earnings has moved 1.37% higher. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.

Our latest available data shows that MET has returned about 3.63% since the start of the calendar year. At the same time, Finance stocks have gained an average of 2.06%. This shows that MetLife is outperforming its peers so far this year.

Breaking things down more, MET is a member of the Insurance - Multi line industry, which includes 27 individual companies and currently sits at #51 in the Zacks Industry Rank. On average, this group has gained an average of 1.60% so far this year, meaning that MET is performing better in terms of year-to-date returns.

Investors in the Finance sector will want to keep a close eye on MET as it attempts to continue its solid performance.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>